Efficacy and tolerability of intravenous immunoglobulin versus intravenous methylprednisolone treatment in anti‐<i>N</i>‐methyl‐<scp>d</scp>‐aspartate receptor encephalitis

Abstract

In patients with NMDAR encephalitis, adequate response, favorable outcome and less recurrence were each more likely to occur in individuals treated with a combined immunotherapy than in monotherapy individuals.